Carly Kenselaar

Item: Carly Kenselaar
Rating: 2.84
Author: StockAnalysis.com

Stock Analyst at Citigroup

(2.84)

# 1,575

Out of 5,163 analysts

Total ratings

100%

Success rate

87.15%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Carly Kenselaar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KRYS Krystal Biotech	Maintains: Neutral	$155 → $176	$247.26	-28.82%	2	Jul 10, 2025
	TVTX Travere Therapeutics	Maintains: Buy	$35 → $32	$27.80	+15.11%	6	Jun 11, 2025

Krystal Biotech

Jul 10, 2025

Maintains: Neutral

Price Target: $155 → $176

Current: $247.26

Upside: -28.82%

Travere Therapeutics

Jun 11, 2025

Maintains: Buy

Price Target: $35 → $32

Current: $27.80

Upside: +15.11%